<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" width="782px" height="3211px" viewBox="-0.5 -0.5 782 3211" content="&lt;mxfile host=&quot;app.diagrams.net&quot; modified=&quot;2020-06-26T00:02:04.463Z&quot; agent=&quot;5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.116 Safari/537.36&quot; etag=&quot;zd6wlzTlH1KVGJynAUlN&quot; version=&quot;13.3.4&quot; type=&quot;github&quot;&gt;&lt;diagram id=&quot;8JQaeR7ikDl0GVS66GYh&quot; name=&quot;Page-1&quot;&gt;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&lt;/diagram&gt;&lt;/mxfile&gt;" resource="https://app.diagrams.net/?src=about#HMedeler%2Fhtml%2Fmaster%2Fpdf%2Fsvg%2F155_tuberculose.svg"><defs/><g><rect x="20" y="1760" width="760" height="480" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="2360" width="760" height="850" fill="none" stroke="#000000" pointer-events="all"/><rect x="428" y="2380" width="352" height="120" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 345px; height: 1px; padding-top: 2387px; margin-left: 435px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le <b>suivi </b>comprend :</div><div><ul><li>clinique, RXT, bactério jusqu'à négativation</li><li>vision couleurs mensuel pendant ttt EMB</li><li>bilan hépatique</li><ul><li>arrêt PZA si &gt; 3N</li><li>arrêt PZA et INH si &gt; 6N</li></ul></ul></div></div></div></div></foreignObject><text x="435" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le suivi comprend :...</text></switch></g><rect x="98" y="2380" width="330" height="110" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 323px; height: 1px; padding-top: 2387px; margin-left: 105px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le bilan <b>pré-thérapeutique</b> comprend :</div><ul><li>NFS, Na<sup>+</sup>, créat, bilan hépato-rénal, uricémie</li><li>séro VIH, VHB, VHC</li><li>examen ophtalmo + vision couleurs (rifampicine)</li><li>recherche grossesse (pyrazinamide)</li></ul></div></div></div></foreignObject><text x="105" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le bilan pré-thérapeutique comprend :...</text></switch></g><rect x="20" y="1190" width="760" height="500" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="120" width="760" height="950" fill="none" stroke="#000000" pointer-events="all"/><rect x="0" y="100" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 115px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Introduction</div></div></div></foreignObject><text x="40" y="119" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Introduction</text></switch></g><rect x="90" y="140" width="690" height="250" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 132px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>maladie transmissible liée à <b>Mycobacterium tuberculosis</b> (= BK), parfois M. bovis ou M. africanum<br /></li><li><b>BAAR aérobie stricte</b> à croissance lente et à multiplication intra- et extra-cellulaire</li><li>Localisation <b>pulmonaire </b>dans 75%</li><li>chez l'imD : 50% localisations extra-pulmonaires, 25% disséminé, symptômes plus légers</li><li>France </li><ul><li>faible incidence : 7/100 000/an</li><li>surtout IDF, Mayotte, Guyane, migrants d'Afrique subsaharienne, SDF</li><li>ALD pour 2 ans</li></ul><li>Monde</li><ul><li>10M cas/an avec 1.5M décès/an</li><li>F5 décès par maladie, F2 décès par maladie infectieuse<br /></li><li>6% sont des tuberculoses multi-résistantes (surtout ex-URSS, Chine, Inde)</li></ul><li><span style="font-size: 12px">Le traitement cible 3 <b>populations de BK</b> :</span></li><ul><li><span style="font-size: 12px">extra-cellulaires (95%) : contagiosité et symptômes ; ssb INH, RMP et streptomycine</span></li><li><span style="font-size: 12px">intra-cellulaires quiescents ; ssb PZA et RMP</span></li><li><span style="font-size: 12px">extra-cellulaires dans le caséeum : rechute ; ssb RMP</span></li></ul></ul></div></div></div></foreignObject><text x="72" y="144" fill="black" font-family="Karla" font-size="12px">maladie transmissible liée à Mycobacterium tuberculosis (= BK), parfois M. bovis ou M. africanum...</text></switch></g><rect x="20" y="140" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 150px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">généralités</div></div></div></foreignObject><text x="55" y="154" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">généralités</text></switch></g><rect x="90" y="390" width="690" height="230" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 382px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ol><li style="font-size: 12px"><b>Contamination </b>: inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= <b style="font-size: 12px">foyer primaire</b>)</li><li style="font-size: 12px"><span style="font-size: 12px"><b>Primo-infection</b> (= PIT) souvent asymptomatique (= ITL = infection tuberculeuse latente)</span></li><ul style="font-size: 12px"><li style="font-size: 12px">BK phagocytés puis multipliés dans <b style="font-size: 12px">macrophages </b>alvéolaires puis gagnent le gg hilaire. Le <b>complexe primaire</b> <br style="font-size: 12px" />est l'association foyer primaire + adénopathie, pouvant rester visible en RXT pendant des années</li><li style="font-size: 12px">Dans les semaines qui suivent la PIT : <b>réponse immune</b> avec afflux des monocytes épithélioïdes formant les <b>granulomes </b>giganto-cellulaires avec nécrose caséeuse contenant des bacilles quiescents. </li><li style="font-size: 12px">L'ITL est parfois patente avec AEG, érythème noueux, kérato-conjonctivite phlycténulaire, adn cervicales. </li></ul><li><span style="font-size: 12px"><b>Tuberculose maladie</b> (= TM) : multiplication des BK (pendant ou après ITL)</span></li><ul><li><span style="font-size: 12px">5% des ITL font une TM &lt; 2 ans post-PIT, 5% font une TM &gt; 2 ans post-PIT</span></li><li>fris de TM :</li><ul><li>imD, diabète, InRé</li><li>fragilité : imD, âges extrêmes, malnutrition, précarité</li><li>alcool, tabac, toxicomanie</li></ul></ul></ol><div><span style="color: rgba(0 , 0 , 0 , 0) ; font-family: monospace ; font-size: 0px">%3CmxGraphModel%3E%3Croot%3E%3CmxCell%20id%3D%220%22%2F%3E%3CmxCell%20id%3D%221%22%20parent%3D%220%22%2F%3E%3CmxCell%20id%3D%222%22%20value%3D%22%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B3%26amp%3Bnbsp%3Bpopulations%26amp%3Bnbsp%3Bde%20BK%20sont%20%C3%A0%20cibler%20%3A%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bextra-cellulaires%20(95%25)%20%3A%20contagiosit%C3%A9%20et%20sympt%C3%B4mes%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20INH%2C%20RMP%20et%20streptomycine%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bintra-cellulaires%20quiescents%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20PZA%20et%20RMP%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B%26lt%3Bspan%26gt%3Bextra-cellulaires%20dans%20le%20cas%C3%A9eum%20%3A%20rechute%26lt%3B%2Fspan%26gt%3B%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Bfont-family%3A%20%26amp%3B%2334%3Bkarla%26amp%3B%2334%3B%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20RMP%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3B%2Ful%26gt%3B%22%20style%3D%22text%3Bhtml%3D1%3B%22%20vertex%3D%221%22%20parent%3D%221%22%3E%3CmxGeometry%20x%3D%22120%22%20y%3D%22560%22%20width%3D%22430%22%20height%3D%22120%22%20as%3D%22geometry%22%2F%3E%3C%2FmxCell%3E%3C%2Froot%3E%3C%2FmxGraphModel%3E</span><br /></div></div></div></div></foreignObject><text x="72" y="394" fill="#000000" font-family="Karla" font-size="12px">Contamination : inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= foyer primaire)Primo-infection...</text></switch></g><rect x="20" y="390" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 405px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">histoire naturelle</div></div></div></foreignObject><text x="55" y="409" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">histoire na...</text></switch></g><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" transform="translate(2,3)" opacity="0.25"/><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 598px; height: 1px; padding-top: 40px; margin-left: 101px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font style="font-size: 30px">155 - Tuberculose</font></div></div></div></foreignObject><text x="400" y="44" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">155 - Tuberculose</text></switch></g><rect x="90" y="1210" width="690" height="70" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1202px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>signes cliniques évoluant depuis des semaines ou des mois</li><li>RXT : nodules, infiltrats ou cavités des lobes supérieurs et postérieurs</li><li>contexte évocateur : contage, voyage, CSP, imD</li><li>dès la suspicion, isoler le patient jusqu'à 15 jours de ttt</li></ul></div></div></div></foreignObject><text x="77" y="1214" fill="black" font-family="Karla" font-size="12px">signes cliniques évoluant depuis des semaines ou des moisRXT : nodules, infiltrats ou cavités des lobes supérieurs et...</text></switch></g><rect x="20" y="1210" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1220px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">suspicion</div></div></div></foreignObject><text x="55" y="1224" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">suspicion</text></switch></g><rect x="20" y="1300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1315px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">diagnostic<br />positif</div></div></div></foreignObject><text x="55" y="1319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">diagnostic...</text></switch></g><rect x="88" y="1300" width="690" height="240" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1307px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font><b>3 prélèvements</b> en 24h :<br /><ul><li><font><b>ECBC </b>en mycobactériologie (recherche de BAAR)</font></li><ul><li><font>si le patient ne crache pas, <b>tubage gastrique</b> le matin à jeun avant le lever</font></li></ul><li>si échec (3 prélèvements négatifs)</li><ul><li>fibroscopie bronchique avec aspiration dirigée <b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li></ul><li><span style="font-size: 12px">si miliaire</span></li><ul><li><span style="font-size: 12px">fibroscopie bronchique avec aspiration dirigée </span><b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li><li><font color="#202122"><span style="font-size: 12px">hémoc sur milieu isolator</span></font></li><li><font color="#202122"><span style="font-size: 12px">ECBU en mycobactériologie</span></font></li><li><font color="#202122"><span style="font-size: 12px">si leuco-neutropénie : myéloculture</span></font></li></ul><li><span style="color: rgb(32 , 33 , 34)">si extra-pulmonaire :</span><br /></li><ul><li><span style="color: rgb(32 , 33 , 34)">ganglionnaire : ponction ou biopsie-exérèse d'adénopathie accessible</span></li><li><span style="color: rgb(32 , 33 , 34)">neuro-méningée : PL</span></li><li><span style="color: rgb(32 , 33 , 34)">génito-urinaire : ECBU 3 jours de suite</span></li></ul></ul></font></div></div></div></foreignObject><text x="95" y="1319" fill="#000000" font-family="Karla" font-size="12px">3 prélèvements en 24h :...</text></switch></g><rect x="20" y="1540" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1550px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">analyse</div></div></div></foreignObject><text x="55" y="1554" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">analyse</text></switch></g><rect x="90" y="1540" width="690" height="150" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1532px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 10<sup>3</sup><span> bacilles/mL. Répéter les prélèvements si examen direct négatif (n'élimine pas le diagnostic)</span></li><li><span>anapath : granulome épithélioïde gigantocellulaire avec nécrose caséeuse (très évocateur mais non pathognomonique)</span></li><li>culture sur milieux enrichis</li><ul><li>milieu solide (Löwenstein-Jensen) en 3-4 semaines</li><li>milieu liquide en 10-15 jours mais doit être reconfirmé par examen direct</li></ul><li><span style="font-size: 12px">identification (M. tuberculosis ou atypique) par biochimie, culture ou PCR</span></li><li>ATBg obligatoire (2% de MDR : résistent à RMP et INH)</li></ul></div></div></div></foreignObject><text x="77" y="1544" fill="black" font-family="Karla" font-size="12px">examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 103 bacilles/mL. Répéter les...</text></switch></g><rect x="0" y="1170" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1185px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Diagnostic</div></div></div></foreignObject><text x="40" y="1189" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Diagnostic</text></switch></g><rect x="20" y="620" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 635px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">localisations</div></div></div></foreignObject><text x="60" y="639" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">localisations</text></switch></g><rect x="100" y="620" width="680" height="350" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 627px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les formes <b>pulmonaires </b>représentent <b>75%</b> des cas<br /><ul><li><b>Tuberculose pulmonaire commune</b> (la plus classique)</li><ul><li>pas de st spécifique : signes généraux, respiratoires (voire pleural)</li><li>lésions des segments postérieurs des lobes supérieurs (PO2 plus élevée : BK aérobie strict)</li><li>3 types de lésions pouvant s'associer : nodules, infiltrats et cavernes</li></ul><li><span style="font-size: 12px"><b>Miliaire </b>tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme disséminée, généralisée, évolution svt défavorable : doit être pec rapidement</span></li><li><span style="font-size: 12px">PID micronodulaire en "grains de mil" bilatérale (parfois lésions macro-nodulaires si forme évoluée)</span></li></ul><li><span style="font-size: 12px"><b>Pleurésie </b>tuberculeuse</span></li><ul><li>épanchement exsudatif et lymphocytaire, unilatéral</li><li>examen direct positif dans &lt; 10%, culture (liquide ou biopsie) positive dans &lt; 30%, anapath de biopsies pleurales positives dans &gt; 80%</li></ul><li><span style="font-size: 12px"><b>Pneumonie aigüe</b> tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme aigüe rare : ensemencement massif de BK sur lésion excavée avec inflammation intense</span></li><li><span style="font-size: 12px">RXT : comme PAC avec petites excavations</span></li></ul></ul><div>Les formes <b>extra-pulmonaires</b> représentent <b>25%</b> des cas, peuvent toucher tous les organes, mais surtout :</div><div><ul><li>gg (50% des formes extra-pulmonaires) : surtout cervicale et médiastinale</li><li>ostéo-articulaire : surtout spondylodiscite tuberculeuse (= mal de Pott)</li><li>génito-urinaire</li><li>neuro-méningée</li></ul></div></div></div></div></foreignObject><text x="107" y="639" fill="#000000" font-family="Karla" font-size="12px">Les formes pulmonaires représentent 75% des cas...</text></switch></g><rect x="20" y="970" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 985px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">vaccin</div></div></div></foreignObject><text x="60" y="989" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">vaccin</text></switch></g><rect x="100" y="970" width="680" height="80" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 693px; height: 1px; padding-top: 962px; margin-left: 87px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risque</li><li>Administration le plus tôt possible</li><li>Pas de test tuberculinique préalable si nourrisson &lt; 3 mois, mais nécessaire jusqu'à 15 ans</li><li>CI si suspicion VIH ou imD (risque <b>BCGite disséminée</b> potentiellement létale)</li></ul></div></div></div></foreignObject><text x="87" y="974" fill="#000000" font-family="Karla" font-size="12px">Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risqueAdministration le plus tô...</text></switch></g><rect x="20" y="2380" width="78" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 76px; height: 1px; padding-top: 2395px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">bilans</div></div></div></foreignObject><text x="59" y="2399" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">bilans</text></switch></g><rect x="20" y="2780" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 2795px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">traitement</div></div></div></foreignObject><text x="55" y="2799" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">traitement</text></switch></g><rect x="88" y="2780" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2787px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">En général 6 mois : <b>quadrithérapie 2 mois</b> puis <b>bithérapie 4 mois<br /></b></div></div></div></foreignObject><text x="95" y="2799" fill="#000000" font-family="Karla" font-size="12px">En général 6 mois : quadrithérapie 2 mois puis bithérapie 4 mois&#xa;</text></switch></g><rect x="20" y="2530" width="88" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 86px; height: 1px; padding-top: 2540px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">médicaments</div></div></div></foreignObject><text x="64" y="2544" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">médicaments</text></switch></g><rect x="0" y="2340" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 2355px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">TM</div></div></div></foreignObject><text x="30" y="2359" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">TM</text></switch></g><path d="M 218 2810 L 215.5 2810 Q 213 2810 213 2820 L 213 2827.5 Q 213 2835 210.5 2835 L 209.25 2835 Q 208 2835 210.5 2835 L 211.75 2835 Q 213 2835 213 2845 L 213 2852.5 Q 213 2860 215.5 2860 L 218 2860" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 268 2810 L 265.5 2810 Q 263 2810 263 2820 L 263 2827.5 Q 263 2835 260.5 2835 L 259.25 2835 Q 258 2835 260.5 2835 L 261.75 2835 Q 263 2835 263 2845 L 263 2852.5 Q 263 2860 265.5 2860 L 268 2860" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,263,2835)" pointer-events="all"/><rect x="218" y="2810" width="40" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2835px; margin-left: 219px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />PZA<br />EMB</div></div></div></foreignObject><text x="238" y="2839" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><rect x="361" y="2810" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2825px; margin-left: 362px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="381" y="2829" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 411 2810 L 408.5 2810 Q 406 2810 406 2817.5 L 406 2821.25 Q 406 2825 403.5 2825 L 402.25 2825 Q 401 2825 403.5 2825 L 404.75 2825 Q 406 2825 406 2832.5 L 406 2836.25 Q 406 2840 408.5 2840 L 411 2840" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,406,2825)" pointer-events="all"/><path d="M 361 2810 L 358.5 2810 Q 356 2810 356 2817.5 L 356 2821.25 Q 356 2825 353.5 2825 L 352.25 2825 Q 351 2825 353.5 2825 L 354.75 2825 Q 356 2825 356 2832.5 L 356 2836.25 Q 356 2840 358.5 2840 L 361 2840" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="88" y="2890" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2897px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Si CI PZA : <b>trithérapie 3 mois </b>puis <b>bithérapie 6 mois</b></div></div></div></foreignObject><text x="95" y="2909" fill="#000000" font-family="Karla" font-size="12px">Si CI PZA : trithérapie 3 mois puis bithérapie 6 mois</text></switch></g><rect x="158" y="2920" width="40" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2940px; margin-left: 159px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />EMB</div></div></div></foreignObject><text x="178" y="2944" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 158 2920 L 155.5 2920 Q 153 2920 153 2930 L 153 2935 Q 153 2940 150.5 2940 L 149.25 2940 Q 148 2940 150.5 2940 L 151.75 2940 Q 153 2940 153 2950 L 153 2955 Q 153 2960 155.5 2960 L 158 2960" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 208 2920 L 205.5 2920 Q 203 2920 203 2930 L 203 2935 Q 203 2940 200.5 2940 L 199.25 2940 Q 198 2940 200.5 2940 L 201.75 2940 Q 203 2940 203 2950 L 203 2955 Q 203 2960 205.5 2960 L 208 2960" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,203,2940)" pointer-events="all"/><rect x="288" y="2920" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2935px; margin-left: 289px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="308" y="2939" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 288 2920 L 285.5 2920 Q 283 2920 283 2927.5 L 283 2931.25 Q 283 2935 280.5 2935 L 279.25 2935 Q 278 2935 280.5 2935 L 281.75 2935 Q 283 2935 283 2942.5 L 283 2946.25 Q 283 2950 285.5 2950 L 288 2950" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 338 2920 L 335.5 2920 Q 333 2920 333 2927.5 L 333 2931.25 Q 333 2935 330.5 2935 L 329.25 2935 Q 328 2935 330.5 2935 L 331.75 2935 Q 333 2935 333 2942.5 L 333 2946.25 Q 333 2950 335.5 2950 L 338 2950" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,333,2935)" pointer-events="all"/><path d="M 648 2900 L 648 2899.61 L 658 2899.91 L 668 2900.22 L 678 2899.55 L 688 2899.43 L 698 2900.26 L 708 2900.46 L 718 2899.64 L 728 2900.11 L 738 2900.09 L 748 2899.7 L 758 2900 L 758.01 2900 L 758.19 2908 L 757.76 2916 L 758.23 2924 L 757.82 2932 L 758 2940 L 758 2940.31 L 748 2940.12 L 738 2940.35 L 728 2940.22 L 718 2939.39 L 708 2940.65 L 698 2939.85 L 688 2940.46 L 678 2940.11 L 668 2940.58 L 658 2940.33 L 648 2940 L 647.95 2940 L 647.82 2932 L 648.09 2924 L 647.94 2916 L 648.01 2908 L 648 2900 L 648 2900 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2920px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les ATB sont à adapter selon l'ATBg</div></div></div></foreignObject><text x="703" y="2924" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Les ATB sont à ada...</text></switch></g><rect x="108" y="2530" width="672" height="290" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 665px; height: 1px; padding-top: 2537px; margin-left: 115px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les anti-tuberculeux utilisés en <b>1e intention</b> sont :</div><ul><li><b>Isoniazide </b>= INH (RIMIFON)</li><ul><li>EI : <b>hépatite</b>, polynévrite sst-mot si carence B6</li></ul><li><b>Rifampicine </b><span>= RMP (RIMACTAN, RIFADINE)</span><br /></li><ul><li><b>colore en orange</b><span> les larmes, sperme et urines (normal mais prévenir)</span><br /></li><li>intéractions : anticoagulants oraux, pilule oestro-progestative (à changer car rend inefficace), inhibiteurs de protéase, CTC, digitaliques</li></ul><li><span style="font-size: 12px"><b>Pyrazinamine </b>= PZA (PIRILENE)</span></li><ul><li><span style="font-size: 12px">CI si InHep ou InRé, déconseillée si grossesse</span></li><li><span style="font-size: 12px">EI : <b>cytolyse hépatique</b> (plus tardif que INH), hyperuricémie svt ast, rash vasomoteur</span></li></ul><li><span style="font-size: 12px"><b>Ethambutol</b> = EMB (MYAMBUTOL, DEXAMBUTOL)</span></li><ul><li><span style="font-size: 12px">EI : <b>névrite optique rétrobulbaire</b> (fris : posologie élevée, éthylisme chronique, InRé)</span></li></ul></ul><div>En <b>2e intention</b>, on peut utiliser des <b>aminosides </b>(streptomycine et amikacine). Les EI principaux sont les toxicités rénale et auditive. Les <b>FQ </b>sont aussi utilisables en 2e intention</div></div></div></div></foreignObject><text x="115" y="2549" fill="black" font-family="Karla" font-size="12px">Les anti-tuberculeux utilisés en 1e intention sont :...</text></switch></g><path d="M 428 2500 L 428 2380" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 648 2780 L 648 2779.72 L 658 2780.61 L 668 2780.72 L 678 2779.55 L 688 2779.38 L 698 2779.84 L 708 2780.08 L 718 2780.52 L 728 2780.35 L 738 2780.02 L 748 2780.7 L 758 2780 L 758.67 2780 L 758.47 2790 L 758.56 2800 L 757.57 2810 L 757.87 2820 L 758 2830 L 758 2829.38 L 748 2830.67 L 738 2829.42 L 728 2830.14 L 718 2829.63 L 708 2830.25 L 698 2830.67 L 688 2829.66 L 678 2830.21 L 668 2829.39 L 658 2830.12 L 648 2830 L 647.41 2830 L 647.31 2820 L 648.24 2810 L 648.02 2800 L 648.67 2790 L 648 2780 L 648 2780 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2805px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si neuro-méningée : durée de 9-12 mois</div></div></div></foreignObject><text x="703" y="2809" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si neuro-méningée...</text></switch></g><path d="M 638 2840 L 638 2839.7 L 648 2839.62 L 658 2840.47 L 668 2839.69 L 678 2840.46 L 688 2840.44 L 698 2839.35 L 708 2839.93 L 718 2839.78 L 728 2839.49 L 738 2839.9 L 748 2840.53 L 758 2840 L 758.3 2840 L 757.49 2850 L 757.9 2860 L 757.8 2870 L 757.36 2880 L 758 2890 L 758 2890.47 L 748 2889.41 L 738 2889.73 L 728 2889.92 L 718 2890.73 L 708 2890.34 L 698 2889.89 L 688 2889.28 L 678 2889.61 L 668 2889.26 L 658 2890.37 L 648 2890.18 L 638 2890 L 638.46 2890 L 638.18 2880 L 638.47 2870 L 637.47 2860 L 638.36 2850 L 638 2840 L 638 2840 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 118px; height: 1px; padding-top: 2865px; margin-left: 639px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si miliaire très sévère : ajout CTC</div></div></div></foreignObject><text x="698" y="2869" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si miliaire très sév...</text></switch></g><rect x="90" y="1780" width="690" height="170" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1787px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px">Les 2 moyens de dépister les ITL sont :</div><div style="font-size: 12px"><ul style="font-size: 12px"><li style="font-size: 12px"><b style="font-size: 12px">IDR </b>(= intradermoréaction) = RCT (= réaction cutanée tuberculinique) </li><ul style="font-size: 12px"><li style="font-size: 12px">interprétation difficile si vaccin BCG &lt; 10 ans car se positive avec M. bovis</li><li style="font-size: 12px">lecture à 72h : IDR positive si induration &gt; 5 mm</li><li style="font-size: 12px">suspicion ITL si <b style="font-size: 12px">&gt; 10 mm sans BCG</b> ou augmentation<b style="font-size: 12px"> 10 mm entre 2 IDR en 3 mois</b></li></ul><li style="font-size: 12px"><b style="font-size: 12px">IGRA </b>(détection de production d'<span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">IFN</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">-</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">γ) par prise de sang</span></li><ul style="font-size: 12px"><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">meilleure VPP que l'IDR (osef BCG)</span></li><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">résultats après qq jours</span></li></ul></ul></div></div></div></div></foreignObject><text x="97" y="1799" fill="black" font-family="Karla" font-size="12px">Les 2 moyens de dépister les ITL sont :...</text></switch></g><path d="M 598 1210 L 598 1210.11 L 608 1209.25 L 618 1209.54 L 628 1209.36 L 638 1210.65 L 648 1209.65 L 658 1210.54 L 668 1209.9 L 678 1209.76 L 688 1210 L 698 1209.77 L 708 1210.56 L 718 1209.49 L 728 1210.04 L 738 1209.55 L 748 1209.41 L 758 1210 L 758.34 1210 L 757.55 1220 L 757.37 1230 L 757.27 1240 L 757.62 1250 L 757.92 1260 L 758 1270 L 758 1270.27 L 748 1270.09 L 738 1270.58 L 728 1270.1 L 718 1270.12 L 708 1270.03 L 698 1269.42 L 688 1269.71 L 678 1269.74 L 668 1269.29 L 658 1270.05 L 648 1269.68 L 638 1269.48 L 628 1270.41 L 618 1269.72 L 608 1270.74 L 598 1270 L 598.15 1270 L 598.33 1260 L 597.65 1250 L 597.46 1240 L 598.38 1230 L 598.15 1220 L 598 1210 L 598 1210 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 158px; height: 1px; padding-top: 1240px; margin-left: 600px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"><span>Déclaration ARS :</span></div>- ITL d'enfant &lt; 15 ans<br />- TM confirmée ou suspectée</div></div></div></foreignObject><text x="600" y="1244" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration ARS :- ITL d'e...</text></switch></g><rect x="0" y="1740" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1755px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ITL</div></div></div></foreignObject><text x="30" y="1759" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ITL</text></switch></g><rect x="20" y="1780" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1790px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">dépistage</div></div></div></foreignObject><text x="55" y="1794" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">dépistage</text></switch></g><rect x="228" y="1950" width="60" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1960px; margin-left: 229px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">contact</div></div></div></foreignObject><text x="258" y="1964" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">contact</text></switch></g><path d="M 243 1970 L 210.64 1987.03" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 205.99 1989.48 L 210.55 1983.12 L 210.64 1987.03 L 213.81 1989.32 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 273 1970 L 294.88 1986.21" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 299.1 1989.33 L 291.39 1987.98 L 294.88 1986.21 L 295.56 1982.36 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 180.02 2020 L 180.15 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 180.16 2138.88 L 176.65 2131.89 L 180.15 2133.63 L 183.65 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="130" y="1990" width="100" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 2005px; margin-left: 132px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- enfant &lt; 2 ans<br />- imD sévère</div></div></div></foreignObject><text x="132" y="2009" fill="#000000" font-family="Karla" font-size="12px">- enfant &lt; 2 ans...</text></switch></g><rect x="130" y="2140" width="380" height="70" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe center; width: 378px; height: 1px; padding-top: 2147px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CHIMIOPROPHYLAXIE</div></div></div></foreignObject><text x="320" y="2159" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">CHIMIOPROPHYLAXIE</text></switch></g><rect x="280" y="1990" width="80" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 78px; height: 1px; padding-top: 2015px; margin-left: 282px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- répété<br />- rapproché<br />- fragile</div></div></div></foreignObject><text x="282" y="2019" fill="#000000" font-family="Karla" font-size="12px">- répété...</text></switch></g><rect x="370" y="1975" width="190" height="60" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 188px; height: 1px; padding-top: 2005px; margin-left: 372px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px">- avant ttt <span style="color: rgb(34 , 34 , 34) ; background-color: rgb(255 , 255 , 255) ; font-size: 12px">anti-TNFα<br /></span>- bilan VIH<br />- pro. santé<br />- migrants &lt; 15 ans forte endémie<br /></font></div></div></div></foreignObject><text x="372" y="2009" fill="#000000" font-family="Karla" font-size="12px">- avant ttt anti-TNFα...</text></switch></g><path d="M 320 2090 L 320 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2138.88 L 316.5 2131.88 L 320 2133.63 L 323.5 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="280" y="2060" width="80" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 2075px; margin-left: 281px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IDR ou IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="320" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IDR ou IGRA&#xa;</text></switch></g><path d="M 320 2040 L 320 2053.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2058.88 L 316.5 2051.88 L 320 2053.63 L 323.5 2051.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 465 2035 L 465 2058.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465 2063.88 L 461.5 2056.88 L 465 2058.63 L 468.5 2056.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="340" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 341px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">bithérapie 3-4 mois<br /><div><span style="font-size: 14px ; font-weight: 400 ; background-color: rgb(255 , 255 , 255)">(INH + RMP)</span></div></div></div></div></foreignObject><text x="425" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">bithérapie 3-4 mois...</text></switch></g><rect x="300" y="2170" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2180px; margin-left: 301px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; "><span style="font-weight: normal">ou</span></div></div></div></foreignObject><text x="320" y="2184" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">ou</text></switch></g><rect x="130" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">monothérapie 6-9 mois<br /><span style="font-weight: normal">(INH)</span></div></div></div></foreignObject><text x="215" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">monothérapie 6-9 mois...</text></switch></g><rect x="125" y="2065" width="110" height="30" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2080px; margin-left: 126px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ne pas attendre la<br />confirmation d'ITL</div></div></div></foreignObject><text x="180" y="2084" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ne pas attendre la...</text></switch></g><path d="M 465.02 2085 L 465.14 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465.16 2138.88 L 461.64 2131.89 L 465.14 2133.63 L 468.64 2131.87 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="445" y="2065" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2075px; margin-left: 446px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="465" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IGRA&#xa;</text></switch></g><rect x="396" y="1950" width="100" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 1960px; margin-left: 398px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px"><b>autres situations</b><br /></font></div></div></div></foreignObject><text x="398" y="1964" fill="#000000" font-family="Karla" font-size="12px">autres situation...</text></switch></g><rect x="377" y="2100" width="210" height="20" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 208px; height: 1px; padding-top: 2110px; margin-left: 378px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div>ssi &lt; 18 ans, imD ou ITL récent (&lt; 1 an)<br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="482" y="2114" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ssi &lt; 18 ans, imD ou ITL récent (&lt;...</text></switch></g><rect x="20" y="1950" width="50" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 48px; height: 1px; padding-top: 1960px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CAT</div></div></div></foreignObject><text x="45" y="1964" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">CAT</text></switch></g><rect x="20" y="2990" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 3005px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">cas particuliers</div></div></div></foreignObject><text x="55" y="3009" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">cas particu...</text></switch></g><rect x="90" y="2990" width="690" height="210" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 2982px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>grossesse</li><ul><li>supplémenter en B6 (INH), K1 (RMP)</li><li>en France, PZA déconseillée pendant grossesse et allaitement</li></ul><li>InRé</li><ul><li>clairance &gt; 30 : ttt normal</li><li>clairance = 15-30 : diminuer EMB, PZA</li><li>clairance &lt; 15 ou dialyse : diminuer INH, EMB, PZA</li></ul><li><span style="font-size: 12px">InHep</span></li><ul><li><span style="font-size: 12px">transaminases = 3-6N asymptomatique : arrêt PZA (peut être repris si retour à la normale)</span></li><li><span style="font-size: 12px">transaminases &gt; 6N ou symptomatique : arrêt INH et PZA voire du ttt antituberculeux</span></li></ul><li><span style="font-size: 12px">tuberculoses multi-résistantes</span></li><ul><li><span style="font-size: 12px">MDR (VS INH et RMP) : représente 2% des tuberculoses en France, ttt de 2e intention (aminosides, FQ)</span></li><li><span style="font-size: 12px">XDR (MDR + FQ + ...) : très mortelle mais exceptionnelle en France</span></li></ul></ul></div></div></div></foreignObject><text x="77" y="2994" fill="#000000" font-family="Karla" font-size="12px">grossesse...</text></switch></g><path d="M 603 1310 L 603 1310.4 L 613 1309.54 L 623 1310.08 L 633 1310.68 L 643 1309.34 L 653 1310.21 L 663 1309.52 L 673 1310.5 L 683 1310.07 L 693 1309.8 L 703 1310.73 L 713 1309.77 L 723 1310.58 L 733 1310.43 L 743 1309.73 L 753 1310 L 752.58 1310 L 753.1 1320 L 752.26 1330 L 752.73 1340 L 753.39 1350 L 753 1360 L 753 1360.38 L 743 1359.44 L 733 1359.29 L 723 1359.42 L 713 1360.23 L 703 1360.38 L 693 1359.54 L 683 1360.62 L 673 1360.21 L 663 1359.42 L 653 1360.29 L 643 1360.63 L 633 1359.64 L 623 1360.15 L 613 1359.37 L 603 1360 L 602.8 1360 L 602.64 1350 L 603.25 1340 L 603.47 1330 L 603.1 1320 L 603 1310 L 603 1310 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 148px; height: 1px; padding-top: 1335px; margin-left: 605px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Déclaration CLAT nominatif pour enquête autour du cas<br /><div style="text-align: center"></div></div></div></div></foreignObject><text x="605" y="1339" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration CLAT nominati...</text></switch></g><rect x="668" y="1280" width="20" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 18px; height: 1px; padding-top: 1290px; margin-left: 669px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 19px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">+</div></div></div></foreignObject><text x="678" y="1296" fill="#000000" font-family="Pangolin" font-size="19px" text-anchor="middle">+</text></switch></g></g><switch><g requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"/><a transform="translate(0,-5)" xlink:href="https://desk.draw.io/support/solutions/articles/16000042487" target="_blank"><text text-anchor="middle" font-size="10px" x="50%" y="100%">Viewer does not support full SVG 1.1</text></a></switch></svg>